Search research articles
Contact Us
Filters
Showing results (921-930 of 1,115) with videos related to
Page
of 112
Sort By:
Current Oncology (Toronto, Ont.)
|
December 31, 2020
Longitudinal health utilities, symptoms and toxicities in patients with <i>ALK-</i>rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessment
B C Tse, B I Said, Z J Fan, et al.
Zhonghua Fu Chan Ke Za Zhi
|
September 22, 2020
[Long-term oncological outcomes of laparoscopic versus abdominal surgery in stage Ⅰa1 （LVSI<sup>+</sup>）-Ⅰb1 cervical cancer patients with different tumor size: a big database in China]
C L Chen, S Kang, B L Chen, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics
|
October 14, 2025
[The efficacy of blinatumomab in the treatment of pediatric B-cell acute lymphoblastic leukemia: a multicenter study]
W L Yan, J Lu, H Wang, et al.
Zhonghua Yi Xue Za Zhi
|
February 6, 2024
[Efficacy and safety of first-line treatment with anti-CD38 monoclonal antibody-based regimen for primary plasma cell leukemia]
X L Dou, R X Liu, Y Liu, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery
|
November 1, 2015
Topic: Incisional Hernia - The "risky" zone: sovrapubic, subxifoid, sub costal
A Majumder, E M Pauli, Y W Novitsky, et al.
Nature Medicine
|
September 6, 2000
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
C Peyron, J Faraco, W Rogers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2014
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†
M Piccart, G N Hortobagyi, M Campone, et al.
Frontiers in Immunology
|
September 8, 2025
Multiplex engineering using microRNA-mediated gene silencing in CAR T cells
Giulia Golinelli, John Scholler, Audrey Roussel-Gervais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial
L Paz-Ares, E-H Tan, K O'Byrne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 16, 2020
Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study
R L Ferris, R Haddad, C Even, et al.
Page
of 112
Search research articles
Search
Showing results (921-930 of 1,115) with videos related to
Sort By:
Page
of 112
Current Oncology (Toronto, Ont.)
|
December 31, 2020
Longitudinal health utilities, symptoms and toxicities in patients with <i>ALK-</i>rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessment
B C Tse, B I Said, Z J Fan, et al.
Zhonghua Fu Chan Ke Za Zhi
|
September 22, 2020
[Long-term oncological outcomes of laparoscopic versus abdominal surgery in stage Ⅰa1 （LVSI<sup>+</sup>）-Ⅰb1 cervical cancer patients with different tumor size: a big database in China]
C L Chen, S Kang, B L Chen, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics
|
October 14, 2025
[The efficacy of blinatumomab in the treatment of pediatric B-cell acute lymphoblastic leukemia: a multicenter study]
W L Yan, J Lu, H Wang, et al.
Zhonghua Yi Xue Za Zhi
|
February 6, 2024
[Efficacy and safety of first-line treatment with anti-CD38 monoclonal antibody-based regimen for primary plasma cell leukemia]
X L Dou, R X Liu, Y Liu, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery
|
November 1, 2015
Topic: Incisional Hernia - The "risky" zone: sovrapubic, subxifoid, sub costal
A Majumder, E M Pauli, Y W Novitsky, et al.
Nature Medicine
|
September 6, 2000
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
C Peyron, J Faraco, W Rogers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2014
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†
M Piccart, G N Hortobagyi, M Campone, et al.
Frontiers in Immunology
|
September 8, 2025
Multiplex engineering using microRNA-mediated gene silencing in CAR T cells
Giulia Golinelli, John Scholler, Audrey Roussel-Gervais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial
L Paz-Ares, E-H Tan, K O'Byrne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 16, 2020
Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study
R L Ferris, R Haddad, C Even, et al.
Page
of 112